Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Nasopharyngeal Diseases × Re-Irradiation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 3 Head and Neck Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Diseases 1 Nasopharyngeal Carcinoma 1 Glioma 1 Carcinoma, Squamous Cell 1

Interventions

Re-Irradiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03854838 2022-04-29

IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.

Sun Yat-sen University

Phase 2 Unknown

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡